PND18 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1291
https://www.valueinhealthjournal.com/article/S1098-3015(19)31483-4/fulltext
Title :
PND18 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31483-4&doi=10.1016/j.jval.2019.04.1291
First page :
Section Title :
Open access? :
No
Section Order :
10798